Skip to contentSkip to footer
A woman in a white lab coat examines a sample through a microscope in a laboratory, with shelves of colourful items in the background.

Become a Royal Marsden Pioneer  

Sign up to a monthly donation and help more people get tomorrow’s cancer treatments, today.Your support for The Royal Marsden Cancer Charity could help fund pioneering research that will lead to new life-saving treatments for patients, across the UK and around the world. 

Your monthly gift could save more lives 

The Royal Marsden is renowned for leading and pioneering the research behind life-saving treatments for people with cancer everywhere. With one in two of us likely to receive a diagnosis in our lifetime, cancer touches every family, generation and community, which is why we need new research breakthroughs more than ever before. 

For every £1 we raise 73p is made available for The Royal Marsden’s groundbreaking work.*

You don't have to develop a new cancer treatment to be a Royal Marsden Pioneer, simply set up a monthly donation today. You will receive a free keyring as a token of our thanks.

“Research has ultimately saved my life.” 

When Pip, a former nurse, was diagnosed with stage 4 metastatic bowel cancer in 2016, she was told her cancer couldn’t be cured.  

Pip's cancer had a genetic mutation which meant she was able to undergo targeted antibody treatment. Initially this helped shrink her tumours, but when Pip underwent a liver resection and hysterectomy surgery, her doctors saw that some of her tumours had started to grow again. Pip was also found to have a rare gene defect which made her eligible for an immunotherapy trial taking place at The Royal Marsden.  

Thanks to the trial, over 8 years on from her diagnosis, Pip's scans are still showing no evidence of disease.

A woman with red hair, wearing a floral blouse, sits on a purple medical chair in a clinical setting with natural light streaming through a window and equipment visible nearby.

“Thanks to CAR-T therapy, I’ve now got my life back” 

77-year-old Richard was diagnosed with myeloma, a type of blood cancer in August 2023. After hearing about research at The Royal Marsden, Richard joined the CARTITUDE-5 study and underwent CAR-T treatment in September.  He was the first CAR-T patient to be treated in Sutton. CAR-T is a type of immunotherapy, personalised for each individual patient by collecting and re-engineering their T cells, harnessing the patient’s own immune system to fight cancer.   

Cancer rates are set to rise by 40% by 2025 Source: JAMA Oncology estimates a 41.7% rise in very high–HDI countries and IARC/WHO data show a 37% increase in the UK.

*2024/25 annual report

Header image photographer: Kirsten Holt

Become a Royal Marsden Pioneer and help support life-saving research